2024 annual financial data

LENZ Therapeutics 2024 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -58,610,000 USD and net income was -49,769,000 USD.
Operating cash flow was -59,391,000 USD.

Get free LENZ Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-58,610,000 USD
Net income
-49,769,000 USD
Operating cash flow
-59,391,000 USD